ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.137,86
-0,44%
S&P 500
5.473,23
0,77%
US Dollar vs BRL
5,4236
-0,04%
Bitcoin
65.476,27
-1,52%
Brent Oil
83,685
-0,26%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. DMK Pharmaceuticals Corporation (DMK)

  7. DMK Pharmaceuticals Corporation (DMK) Notícias

DMK

DMK Pharmaceuticals (DMK)

DMK Pharmaceuticals Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMK
DataHoraFonteTítuloCódigoCompanhia
21/03/202415:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
07/02/202419:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
06/02/202412:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
23/01/202419:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
21/12/202310:15GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHINASDAQ:DMKDMK Pharmaceuticals Corporation
28/11/202310:05GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
14/11/202309:30GlobeNewswire Inc.DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
13/11/202312:52GlobeNewswire Inc.DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023NASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202317:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202317:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
30/10/202308:30GlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
19/10/202317:05GlobeNewswire Inc.DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of GrowthNASDAQ:DMKDMK Pharmaceuticals Corporation
17/10/202313:28Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNASDAQ:DMKDMK Pharmaceuticals Corporation
12/10/202317:22Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
02/10/202317:49Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
26/09/202309:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
07/09/202313:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:DMKDMK Pharmaceuticals Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMK

Seu Histórico Recente

EU
SAGAF
Sagess Med Term Notes 3....
TG
1YJA
LM Funding America
NASDAQ
LIAWX
Lifex Inflationprotected...
GDAX
HIGHUSD
Highstreet token
USOTC
ICHBF
Industrias Ch Sa de Cv Ich (CE)
BOV
BSLI4F
BRB BANCO PN
NASDAQI
OMXBBPI
OMX Baltic Benchmark PI
USOTC
ARZTF
Arzyta (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados